PDCD1 and neoplasm: We characterized the phenotype and functional capacity of PD-1pos NK cells compared to their PD-1neg counterparts and evaluated the impact of PD-1:PD-L1 blockade on the tumor-specific activity of NK cells against both primary NK cells and NK lines.